🔴 First Tracks Biotherapeutics is trading 5% down today as Brent crude nears $100 amid regional conflict

First Tracks Biotherapeutics is trading 5.12% down now at $39.66, moving lower alongside a weak September 9, 2026 market amid elevated oil prices and Middle East tensions.

• Nasdaq Composite and Dow Jones Industrial Average are down more than 0.5%.
• Reuters reported Brent crude nearing $100 per barrel amid escalating regional conflict.
• The Wells Fargo Healthcare Conference occurred on September 9, 2026; available coverage describes pipeline updates, not a negative company-specific announcement, so the decline appears primarily global rather than company-driven.